These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220 [No Abstract] [Full Text] [Related]
30. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227 [TBL] [Abstract][Full Text] [Related]
31. Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. Grochowicz PM; Hibberd AD; Bowen KM; Clark DA; Pang G; Cowden WB; Chou TC; Grochowicz LK; Smart YC Transplant Proc; 1997; 29(1-2):1259-60. PubMed ID: 9123296 [No Abstract] [Full Text] [Related]
32. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin. Shapira OM; Rene H; Lider O; Pfeffermann RA; Shemin RJ; Cohen IR J Surg Res; 1999 Jul; 85(1):83-7. PubMed ID: 10383842 [TBL] [Abstract][Full Text] [Related]
33. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy. Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699 [No Abstract] [Full Text] [Related]
34. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments. Chen Z; Cobbold S; Waldmann H; Metcalfe S Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482 [No Abstract] [Full Text] [Related]
35. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival. Schrepfer S; Deuse T; Schäfer H; Reichenspurner H Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275 [TBL] [Abstract][Full Text] [Related]
37. Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy. Fujiwara I; Nakajima H; Arakawa K; Akioka K; Takeshita K; Oka T Transplant Proc; 1996 Apr; 28(2):685-6. PubMed ID: 8623345 [No Abstract] [Full Text] [Related]
38. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. Harrison PC; Mainolfi E; Madwed JB J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853 [TBL] [Abstract][Full Text] [Related]
39. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice. Gao L; Woo J; Buelow R J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086 [TBL] [Abstract][Full Text] [Related]
40. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts. Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]